Congress funds menopause research and care—a long-overdue public health priority
S. 4503 — Advancing Menopause Care and Mid-Life Women’s Health Act · Filed by Patty Murray (D-WA) · 18 cosponsors · Introduced May 12, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Health and Human Services to expand research, training, and public awareness programs focused on menopause and mid-life women's health. It authorizes $25 million annually for research and data collection on menopausal symptoms, $10 million for public health promotion and grants to improve early detection and care coordination, $10 million for a national awareness and education program, $10 million for training programs at medical schools and hospitals, and unspecified funding for Centers of Excellence. The bill benefits women experiencing perimenopause and menopause by improving provider training, expanding access to care, and filling research gaps on a condition historically under-studied and under-treated.
Why we flagged it
The bill's core function is to expand federal research, training, and public health infrastructure around menopause and mid-life women's health. It is a straightforward public health authorization bill with no hidden mechanisms or narrow beneficiaries.
What the text implies
- Establishing a federal data dashboard on menopausal symptoms may create the first comprehensive national surveillance system for this condition, potentially shifting how menopause is understood as a public health issue rather than a private medical matter.
- Requiring Centers of Excellence to prioritize health professional shortage areas and medically underserved populations may redirect menopause expertise away from well-resourced urban centers toward rural and low-income communities, reducing geographic disparities in care.
- Mandating provider training across multiple disciplines (physicians, nurses, pharmacists, dentists) may normalize menopause care as a cross-specialty responsibility rather than a gynecology-only issue, changing clinical practice patterns.
- The bill's emphasis on both pharmacological and non-pharmacological treatments and mental health integration may implicitly challenge pharmaceutical-only treatment paradigms and expand coverage for behavioral health services during menopause.
Who it affects
The bill addresses a significant public health gap by funding research, provider training, and care access improvements for menopause—a condition affecting millions of women that has historically received limited medical attention and research funding. The provisions prioritize underserved and rural populations and require equity-focused implementation, directly benefiting ordinary citizens.
Who stands to gain
- medical schools and nursing schools (grant recipients)
- hospitals and health systems (training program funding)
- research institutions (research funding)
- community health centers (care coordination grants)
Named in the bill
Department of Health and Human Services, Public Health Service Act, Senate Committee on Health, Education, Labor, and Pensions, Committee on Appropriations, Committee on Energy and Commerce, Committee on Ways and Means, Special Committee on Aging, Department of Veterans Affairs, Department of Defense, accredited schools of medicine, accredited schools of nursing, accredited schools of pharmacy — and 2 more
Where it stands
18 cosponsors: 17 Democrats, 1 Republicans.
- May 12, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- May 12, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $96,000 in lobbying spend. A filing names 31 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Patty Murray, the sponsor, reported $307,200 in PAC receipts in the 2026 cycle.
- American College of Obstetricians and Gynecologists — $96,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 5, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds menopause research and care—a long-overdue public health priority” QuorumCivic. https://share.quorumcivic.app/bill/119/s4503 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.